LumiThera, Inc.

LumiThera, Inc.

LumiThera is a medical device company commercializing a multiwavelength Photobiomodulation device for the ophthalmologist’s office that improves vision and may slow the progression of vision loss in patients with degenerative eye disease.

About LumiThera

LumiThera is committed to creating brighter horizons for patients by developing treatment solutions utilizing Photobiomodulation to improve visual function, to stop or slow the progression of debilitating eye diseases, and to prevent vision loss and blindness.

LumiThera’s flagship product, the Valeda® Light Delivery System, is the first approved treatment for Dry Age-Related Macular Degeneration using Photobiomodulation. Valeda improves visual acuity, improves contrast sensitivity, reduces central drusen volume, and is designed for ease-of-use in the clinician’s office.

Valeda is CE Marked in Europe and is in clinical trials and not approved for use in the United States. Visit to learn more.




LUMITHERA, INC. Corporate Headquarters
19578 10th Ave NE STE 200 Poulsbo
Washington 98370



Quality and Regulatory Credentials:

EU CE Cert and ISO 13485 Quality Cert  |  Columbia Approval and ISO 13485 Quality Cert
Argentina Approval and ISO 13485 Quality Cert

  • INVESTMENT Gold Sponsor
  • Website
  • Contact
  • Follow

You are being transferred to Easychair—our Abstract Submission platform—where you will be prompted to create an account. Once you have created an account, follow the simple prompts to submit your abstract. Please indicate your preference for podium presentation, or if you prefer a poster presentation, include the word "Poster" after your keywords.

If your abstract is accepted, you will be required to register for the meeting before presenting.

Further registration instructions will be posted to this website when they come available.